Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

15:55 EST 20th November 2017 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 988 from PMLIVE

Monday 20th November 2017

Amsterdam picked to host the European Medicines Agency

EMA will move to the Netherlands city when the UK leaves the EU

New data could unlock bigger market for Roche’s Hemlibra

Trial shows the drug ‘significantly’ reduced bleeds in haemophilia A patients without inhibitors

Sutent gets FDA approval for early use in kidney cancer

Decision could help Pfizer combat competition from Bristol-Myers Squibb's Opdivo and Yervoy

CHMP backs MSD’s CMV infection treatment

Prevymis is set to be available as an injectable and tablets

Sunday 19th November 2017

Roche acquires US laboratory big data company Viewics

Gains cloud-based laboratory business analytics capabilities

Lexington Communications bolsters team with a trio of new-hires

Adds Prof Mike Bewick, Mike Burrows and Katherine Murphy as senior advisors

Conversis appoints Charlotte Terry as client relationship manager

She joins the translation provider from RWS Group

Saturday 18th November 2017

Hanover Brussels appoints Aurélie Marchland as account director

She joins the communications consultancy from Hill & Knowlton Strategies Paris

Friday 17th November 2017

First patient treated with Sangamo’s gene-editing tech

SB-913 uses ZFN technology to insert a corrective gene into the liver cells DNA location

Patently unclear?

The challenge of protecting  biotech innovations

Roche gets first approval for haemophilia A therapy

The first-in-class therapy wins US marketing licence three months earlier than expected

Ketchum London's CEO Denise Kaufmann heads for the US

The UK agency's deputpy CEO Jo-ann Robertson will move into Kaufmann's former role

ThromboGenics bolsters leadership team

Appoints Susan Schneider as CMO and Vinciane Vangeersdaele as CCO

Thursday 16th November 2017

Uptake Strategies and Sanofi win capability development prize at PMEA

Judges praised their programme’s pragmatic design and huge scalability

Lucid picks up rare disease and orphan drugs trophy at PMEA 2017

Judges praised the AbbVie project for its impressive reach

Patient recruitment and engagement standards

Clinical trial awareness

EMA approves GSK’s triple COPD therapy

Trelegy can now be marketed as a maintenance treatment in Europe

NICE backs two advanced breast cancer drugs after price cuts

An estimated 8,000 women will be eligible to receive the drugs due to discounts

AbbVie named PMEA 2017 Company of the Year

Sees off strong competition from Amgen and Sanofi

Sanofi’s diabetes IMPACT programme wins at PMEA 2017

Takes home first place in Excellence in Demonstrating Economic and Societal Value

The EarthWorks wins PMEA Support Agency of the Year

Edges out Complete Medical Communications and Makara Health to take the title

Wednesday 15th November 2017

The state of trust

Roche’s Future-proofing Healthcare event shows  how the current model is a complicated one

AZ prices severe asthma drug Fasenra below competition

The discounted drug will cost $38,000 in the first year

Shire wins CHMP backing for Adynovi

Haemophilia A treatment backed for European approval

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

The German pharma group will gain full rights to the drugs outside the US

Quick Search

News Quicklinks